SCHEMBL1104740

SCHEMBL1104740

CCOC(=O)C1=Cc2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2N=C(N)C1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 20/20 0.74
TLR7 Q9NYK1 14/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12619304 0.99 TLR8 (0.73) TLR8TLR7
SCHEMBL10325097 0.92 TLR8 (0.63) TLR8TLR7
SCHEMBL22790540 0.92 TLR8 (0.72) TLR8TLR7
SCHEMBL23420852 0.90 TLR8 (0.61) TLR8TLR7
SCHEMBL15625323 0.88 TLR8 (0.58) TLR8TLR7
SCHEMBL1802374 0.87 TLR8 (0.73) TLR8TLR7
SCHEMBL1237666 0.86 TLR8 (0.72) TLR8TLR7
SCHEMBL1093906 0.86 TLR8 (0.56) TLR8TLR7
SCHEMBL10343276 0.86 TLR8 (0.56) TLR8TLR7
SCHEMBL23422296 0.85 TLR8 (0.55) TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940797-B1 8-SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS ARRAY BIOPHARMA INC (US) 2012-08-01 EP claimed
EP-2940009-B1 METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES VENTIRX PHARMACEUTICALS INC (US) 2018-10-17 EP disclosed
EP-3081558-A1 8-SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS Array Biopharma, Inc. (US) 2016-10-19 EP disclosed
EP-2940009-A1 METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES VentiRx Pharmaceuticals, Inc. (US) 2015-11-04 EP disclosed
EP-2358683-B1 METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES VENTIRX PHARMACEUTICALS INC (US) 2015-04-01 EP disclosed
EP-2663555-A2 SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS VentiRx Pharmaceuticals, Inc. (US) 2013-11-20 EP disclosed
US-8314090-B2 Methods of synthesis of benzazepine derivatives VENTIRX PHARMACEUTICALS, INC. (US) 2012-11-20 US disclosed
US-8304407-B2 8-substituted benzoazepines as toll-like receptor modulators ARRAY BIOPHARMA INC. (US) 2012-11-06 US disclosed
US-8304407-B2 8-substituted benzoazepines as toll-like receptor modulators ARRAY BIOPHARMA INC. (US) 2012-11-06 US disclosed
EP-1940797-B1 8-SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS ARRAY BIOPHARMA INC (US) 2012-08-01 EP disclosed
WO-2012097177-A2 SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS VENTIRX PHARMACEUTICALS, INC. (US) 2012-07-19 WO disclosed
US-20120165317-A1 8-SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS ARRAY BIOPHARMA INC. (US) 2012-06-28 US disclosed
US-20120165317-A1 8-SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS ARRAY BIOPHARMA INC. (US) 2012-06-28 US disclosed
US-8153622-B2 modulating a patient's immune system; treating autoimmunity, inflammation allergy, asthma, transplant rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency; (1E,4E)-ethyl 2-amino-8-(perfluoroethyl)-3H-benzo[b]azepine-4-carboxylate; antiinflammatory, anticarcinogenic agents ARRAY BIOPHARMA INC. (US) 2012-04-10 US disclosed
US-8153622-B2 modulating a patient's immune system; treating autoimmunity, inflammation allergy, asthma, transplant rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency; (1E,4E)-ethyl 2-amino-8-(perfluoroethyl)-3H-benzo[b]azepine-4-carboxylate; antiinflammatory, anticarcinogenic agents ARRAY BIOPHARMA INC. (US) 2012-04-10 US disclosed
EP-2322510-A2 8-substituted benzoazepines as toll-like receptor modulators Array Biopharma, Inc. (US) 2011-05-18 EP disclosed
US-20100216989-A1 METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES VENTIRX PHARMACEUTICALS, INC. (US) 2010-08-26 US disclosed
US-20080234251-A1 8-Substituted Benzoazepines as Toll-Like Receptor Modulators ARRAY BIOPHARMA INC. (US) 2008-09-25 US disclosed
US-20080234251-A1 8-Substituted Benzoazepines as Toll-Like Receptor Modulators ARRAY BIOPHARMA INC. (US) 2008-09-25 US disclosed
WO-2007024612-A2 8-SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS ARRAY BIOPHARMA INC. (US) 2007-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165317-A1 8-SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS TLR8, TLR7, TLR9 TLR8 1/4885TLR7 2/4885
US-20100216989-A1 METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES MAOB, GABBR1, HNMT TLR8 4758/4885TLR7 4486/4885
US-20080234251-A1 8-Substituted Benzoazepines as Toll-Like Receptor Modulators TLR8, TLR7, TLR9 TLR8 1/4885TLR7 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.